Evidence map›Paper›PMID 42523319›Full record

ArticlebioRxiv : the preprint server for biology2026

α-Synuclein pathology differentially alters T-type calcium currents in vulnerable and resilient substantia nigra dopaminergic subpopulations.

Megan L Beaver, Pallavi Bommareddy, Natalie Z McLean, Valerie J Lewitus, Kathleen Maguire-Zeiss, Rebekah C Evans

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Megan L BeaverDepartment of Neuroscience, Georgetown University School of Medicine, Georgetown University Medical Center, Washington, DC, USA 20007.ORCID 0000-0002-5203-0354
Pallavi BommareddyDepartment of Neuroscience, Georgetown University School of Medicine, Georgetown University Medical Center, Washington, DC, USA 20007.ORCID 0009-0005-2426-067X
Natalie Z McLeanDepartment of Neuroscience, Georgetown University School of Medicine, Georgetown University Medical Center, Washington, DC, USA 20007.
Valerie J LewitusDepartment of Neuroscience, Georgetown University School of Medicine, Georgetown University Medical Center, Washington, DC, USA 20007.ORCID 0000-0002-6456-6156
Kathleen Maguire-ZeissDepartment of Neuroscience, Georgetown University School of Medicine, Georgetown University Medical Center, Washington, DC, USA 20007.ORCID 0000-0002-2868-848X
Rebekah C EvansDepartment of Neuroscience, Georgetown University School of Medicine, Georgetown University Medical Center, Washington, DC, USA 20007.ORCID 0000-0002-9476-150X

Funding

Pharmacological Sciences Training Program (PSTP)T32GM142520 · NIGMS · GEORGETOWN UNIVERSITY · PI Patrick Alexander Forcelli, Anton Wellstein · 2022 to 2026
$1.3M
Chronic nicotine effects on vulnerable brainstem neuronsR01NS142876 · NINDS · GEORGETOWN UNIVERSITY · PI Rebekah Coleman Evans · 2026 to 2026
$531k
NIGMS NIH HHS T32 GM142520NINDS NIH HHS R01 NS142876
6 · The paper itself

Abstract

Aggregation of α-synuclein protein is a characteristic of Parkinson's disease pathology that relates to the degeneration of vulnerable dopaminergic neurons and motor symptoms of the disease. However, α-synuclein pathology can contribute to neuronal dysfunction by disrupting several processes within the cell, including intracellular calcium balance, mitochondrial function, and synaptic function. Here, we use a preformed fibril (PFF) model of synucleinopathy to examine effects of striatal α-synuclein seeding on dopamine neurons of the substantia nigra

Identifiers

PMID42523319
PMCPMC13404962

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.